About 200 reports

The global benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven owing to the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing...

  • Therapy
  • World
  • North America
  • Europe
  • United States
  • Japan
  • APAC
  • Overweight Prevalence
  • Drug Approval

The Netherton syndrome market was valued at US$ 19.57 million in 2019 and is projected to reach US$ 74.31 million by 2027; it is expected to grow at a CAGR of 20.3%during 2020–2027. The growth of the Netherton syndrome market is mainly attributed to factors such as the rising number of awareness campaigns, and increasing number of drug...

  • Therapy
  • Epidemiology
  • World
  • United States
  • APAC
  • Europe
  • France
  • Germany
  • United Kingdom
  • Spain
  • Japan
  • Italy
  • Drug Approval
  • Final Consumption Expenditures

Exportin 1 - Drugs In Development, 2021 Summary Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Exportin 1 - Drugs In Development, 2021, outlays...

  • Therapy
  • Drug Development
  • World
  • Stem Cell Transplantation
  • Drug Approval

Abstract: - Global Alpha 1 Antitrypsin Deficiency Treatment Market to Reach $2.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Alpha 1 Antitrypsin Deficiency Treatment estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR...

  • Respiratory Treatment
  • Hormone
  • World
  • China
  • United States
  • Europe
  • Japan
  • APAC
  • Canada

Abstract: What’s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Therapy
  • World
  • China
  • United States
  • Europe
  • Japan
  • APAC
  • Canada

Acyl CoA Desaturase - Pipeline Review, H2 2020 Summary According to the recently published report ’Acyl CoA Desaturase - Pipeline Review, H2 2020’; Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) pipeline Target constitutes close...

  • Therapy
  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Japan
  • Pharmaceutical Exports
  • Smoking Prevalence

Exportin 1 - Pipeline Review, H2 2020 Summary Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close to 8 molecules. The latest report Exportin 1 - Pipeline Review, H2 2020, outlays comprehensive information on the Exportin 1 (Chromosome Region Maintenance...

  • Therapy
  • Drug Development
  • World
  • Stem Cell Transplantation
  • Drug Approval

This industry analysis report tackles the major orphan drugs within the rare disease therapeutic market and encompasses the most prevalent and dominant therapies in this space. The market value for the current major orphan therapeutic space is analysed and forecast to 2025 with corresponding CAGR percentages. Market details are provided by...

  • Therapy
  • World
  • Europe
  • APAC
  • North America
  • China
  • South Korea
  • Japan
  • United States

“Myasthenia Gravis – Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Neurological Disorder
  • Therapy
  • World
  • Japan
  • United States
  • European Union

"Japan Cancer Drug Market, Dosage, Price & Clinical Trials Insight 2025" Report Highlights: • Japan Cancer Drug Market Opportunity: > US$ 15 Billion by 2025 • Insight on Cancer Drugs In Clinical Trials: 360 Drugs • Ongoing Clinical Trials for Cancer Drugs: 1600 Trials • Marketed Cancer Drug Clinical...

  • Oncology
  • Japan
  • Drug Approval

“NMDA Receptor Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in NMDA Receptor Antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Opioid
  • France
  • Japan
  • World

“Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Fms-like tyrosine kinase 3 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by...

  • Therapy
  • Leukemia
  • South Korea
  • Japan
  • World

“Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers...

  • Therapy
  • Japan
  • World

“Cell wall inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Cell wall inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Anti-Infective
  • Japan
  • World

“Janus Kinase (JAK) Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Janus Kinase (JAK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type,...

  • Immunotherapy
  • Therapy
  • Cell Therapy
  • World
  • Europe
  • Japan

Major players in the conjugated monoclonal antibodies market are Pfizer Inc., F. Hoffmann-LA, Bristol -Myers Squibb, Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., and Spectrum Pharmaceuticals Inc. The global conjugated monoclonal...

  • Monoclonal Antibody
  • Biopharmaceutical
  • World
  • Japan
  • Middle East
  • United States
  • APAC
  • United Kingdom

Major players in the conjugated monoclonal antibodies market are Pfizer Inc., F. Hoffmann-LA, Bristol -Myers Squibb, Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., and Spectrum Pharmaceuticals Inc. The global conjugated monoclonal...

  • Monoclonal Antibody
  • Biopharmaceutical
  • World
  • United States
  • Japan
  • APAC
  • United Kingdom

Major players in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc. and Gedeon Richter Plc. The global parathyroid hormone market is expected to grow from $2.02 billion in 2021 to $2.15 billion in 2022 at a compound annual growth...

  • Hormone
  • World
  • United States
  • Japan
  • Middle East
  • APAC

‘focal segmental glomerulosclerosis (FSGS) – Market Insights, Epidemiology, and Market Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of focal segmental glomerulosclerosis (FSGS) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom),...

  • Therapy
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure

" Developmental and Epileptic Encephalopathy - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well as the DEE market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The DEE market...

  • Therapy
  • Neurological Disorder
  • United States
  • Japan
  • Germany
  • Spain
  • France
  • United Kingdom
  • Italy
  • Drug Approval
  • Inflation Rate

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fits-all’...

  • Infectious Disease
  • Pharmaceutical
  • Artificial Intelligence
  • Therapy
  • Big Data
  • Neurology
  • Cardiovascular Disease
  • Managed Care
  • Bioinformatics
  • China
  • Japan
  • World
  • Taiwan
  • South Korea
  • Australia
  • Singapore
  • United States
  • European Union
  • Canada

Pediatric Vaccines: Epidemiology Forecast to 2028 Summary Pediatric vaccination rates are set to reach nearly 90% in the combined nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Canada, and India) by 2028; this represents a high compliance in children at or under age two years...

  • Vaccine
  • Japan
  • India
  • Italy
  • United States
  • World
  • Germany
  • Canada
  • Spain
  • France
  • United Kingdom
  • Vaccination Coverage
  • Child Immunisation Coverage

“Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Proto-oncogene protein c mdm2 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Cancer
  • World
  • Japan

“Complement C5 Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Complement C5 Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Monoclonal Antibody
  • United States
  • Japan
  • European Union

“Chemotherapy Induced Anemia- Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chemotherapy Induced Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage,...

  • Blood Disease
  • Chemotherapy
  • World
  • China
  • Europe
  • United States
  • Chile
  • South Korea
  • Japan
  • Energy Supply

“Coronavirus-3C-like-proteinase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Coronavirus-3C-like-proteinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Infectious Disease
  • Therapy
  • HIV Antiviral
  • Clinical Trial
  • Taiwan
  • Japan
  • World

“Sodium Channel Blockers - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Sodium Channel Blockers pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Therapy
  • Biopharmaceutical
  • Clinical Development
  • Chronic Pain
  • Japan
  • World

Topical analgesics/anaesthetic continues to struggle in 2021 and is expected to maintain a double-digit decline. Many brands which are popular amongst inbound tourists, such as Salonpas (Hisamitsu Pharmaceutical) and Vantelin (Kowa), have faced headwinds. This is due to restrictions on the entry of tourists to prevent the spread of COVID-19...

  • Analgesic
  • Japan
  • Analgesic Medicine Sales
  • Over The Counter Drug Sales

Danyelza Patent, Sales & Clinical Trials Outlook 2028 Report Analysis & Data Highlights: • Danyelza Patent Insight • Danyelza Dosage & Price  • Danyelza Sales Forecast 2028: > USD 400 Million • Danyelza Role in Neuroblastoma & Osteosarcoma Therapy • Danyelza Structure & Pharmacokinetics...

  • Cancer
  • Clinical Trial
  • Therapy
  • World
  • Europe
  • United States
  • China
  • Japan
  • Out Of Pocket Expenditure

‘Acute Respiratory Distress Syndrome-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Acute Respiratory Distress Syndrome, historical and forecasted epidemiology as well as the Acute Respiratory Distress Syndrome market trends in the United States, EU5 (Germany, France, Italy, Spain,...

  • Therapy
  • United States
  • France
  • Germany
  • Japan
  • Italy
  • United Kingdom
  • Spain